Dr. Sammantha Jeane Kouba, DO

Dr. Kouba practices at Sanford Medical Center Fargo - Laboratory in Fargo, North Dakota.

Dr. Kouba's NPI, 1760877344, was assigned on April 1, 2015. Dr. Kouba holds North Dakota license 16710.

Dr. Kouba's primary practice is Sanford Medical Center Fargo - Laboratory, at 5225 23rd Ave S Route 4541, Fargo, ND 58104. The practice phone is (701) 417-2784.

Dr. Kouba's primary practice is Sanford Medical Center Fargo - Laboratory in Fargo, North Dakota. Dr. Kouba is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Dr. Kouba to 1 more hospital, named with a free account. Dr. Kouba's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kouba practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Kouba's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Kouba's licenses on file in 3 states: North Dakota, Iowa and Oregon.

CMS data shows 261 Medicare services from Dr. Kouba across 4 procedure codes in 2024, for 121 Medicare patients. Medicare paid $18,268 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 121 Medicare patients who saw Dr. Kouba in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 3.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kouba's median patient age at 73, with 51% women.

In 2024, Dr. Kouba wrote 226 Medicare Part D claims for 52 patients. 77% of them were for generic drugs. CMS names the drug for 143 of them, across 9 drugs with 11 or more claims each, at $183,824 in total drug cost. In 2023, CMS named 94 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kouba for performance year 2024, reported as part of a group. Dr. Kouba accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kouba as offering telehealth.

Dmand AI links 3 papers to Dr. Kouba, published from 2020 to 2021. 2020 was the busiest year, with 2. The most frequent topics are Diagnosis, Differential. Dr. Kouba has published most often in BMJ Case Rep. Dr. Kouba's most frequent co-authors are Takaaki Kobayashi, MD, Loreen A. Herwaldt, MD and Daniel Joseph Livorsi, MD.

CMS Open Payments shows 10 general payments to Dr. Kouba from 7 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 92% of the total. Merck Sharp & Dohme Corporation paid the most, $60.